Biogen Inc (NASDAQ: BIIB) – Not A Clear Buying Opportunity?
Biogen Inc (BIIB) concluded trading on Thursday at a closing price of $164.89, with 3.21 million shares of worth about $528.75 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -28.32% during that period and on November 14, 2024 the price saw a loss […]
